Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor

Europace

Volumn 13, Issue 2, 2011, Pages 237-243

  Sthlberg, Marcus ^a   Kessels, Roger ^b   Linde, Cecilia ^a   Braunschweig, Frieder ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

Cardiac resynchronization therapy; Haemodynamic; Heart failure; Heart rate

Indexed keywords

AGED; ARTERIAL PRESSURE; ARTICLE; BICYCLE ERGOMETRY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; HEART BEAT; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FILLING PRESSURE; HEART OUTPUT; HEART RATE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE PRESSURE; HEMODYNAMIC MONITORING; HUMAN; IMPLANT; IMPLANTABLE HEMODYNAMIC MONITOR; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

AGED; ATRIOVENTRICULAR NODE; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; EXERCISE; HEART FAILURE; HEART RATE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; RETROSPECTIVE STUDIES; STROKE VOLUME;

EID: 79251499313     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq354     Document Type: Article

References (31)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89.
2. Bowditch HP. Uber die Eigenthumlichkeiten der Reizbarkeit, welche die Muskel-fasern des Herzens zeigen. Ber Sachs Ges (Akad) Wiss 1871;23:652-89.
3. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation 1992;85:1743-50.
4. Feldman MD, Alderman JD, Aroesty JM, Royal HD, Ferguson JJ, Owen RM et al. Depression of systolic and diastolic myocardial reserve during atrial pacing tachy-cardia in patients with dilated cardiomyopathy. J Clin Invest 1988;82:1661-9.
5. Hasenfuss G, Holubarsch C, Hermann HP, Astheimer K, Pieske B, Just H. Influ-ence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyo-pathy. Eur Heart J 1994;15:164-70.
6. Vollmann D, Luthje L, Schott P, Hasenfuss G, Unterberg-Buchwald C. Biventricu-lar pacing improves the blunted force-frequency relation present during univen-tricular pacing in patients with heart failure and conduction delay. Circulation 2006;113:953-9.
7. Steendijk P, Tulner SA, Bax JJ, Oemrawsingh PV, Bleeker GB, van Erven L et al. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops. Circulation 2006;113:1295-304.
8. Van Thielen G, Paelinck BP, Beckers P, Vrints CJ, Conraads VM. Rate response and cardiac resynchronisation therapy in chronic heart failure: higher cardiac output does not acutely improve exercise performance: a pilot trial. Eur J Cardi-ovasc Prev Rehabil 2008;15:197-202.
9. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Rec-ommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
10. Ritter P, Padeletti L, Gillio-Meina L, Gaggini G. Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endo-cardial acceleration measurements. Europace 1999;1:126-30.
11. Ohlsson A, Bennett T, Nordlander R, Ryden J, Astrom H, Ryden L. Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transdu-cer. J Card Fail 1995;1:161-8.
12. Reynolds DW, Bartelt N, Taepke R, Bennett TD. Measurement of pulmonary arterydiastolic pressure from the rightventricle.JAm Coll Cardiol1995;25:1176- 82.
13. Magalski A, Adamson P, Gadler F, Boehm M, Steinhaus D, Reynolds D et al. Con-tinuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail 2002;8:63-70.
14. Karamanoglu M, McGoon M, Frantz RP, Benza RL, Bourge RC, Barst RJ et al. Right ventricular pressure waveform and wave reflection analysis in patients with pul-monary arterial hypertension. Chest 2007;132:37-43.
15. Stahlberg M, Damgaard M, Ersgard D, Norsk P, Karamanoglu M, Linde C et al. Estimating changes in cardiac output using an implanted hemodynamic monitor in heart failure patients. Scand Cardiovasc J 2010; 44: 201-8.
16. Vanderheyden M, Mullens W, Delrue L, Goethals M, Verstreken S, Wijns W et al. Endomyocardial upregulation ofbeta1 adrenoreceptor gene expression and myo-cardial contractile reserve following cardiac resynchronization therapy.J Card Fail 2008;14:172-8.
17. van Gelder BM, Meijer A, Bracke FA. Stimulation rate and the optimal interven-tricular interval during cardiac resynchronization therapy in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol 2008;31:569-74.
18. Bombardini T. Myocardial contractility in the echo lab: molecular, cellular and pathophysiological basis. Cardiovasc Ultrasound 2005;3:27.
19. Braunschweig F. Therapeutic and diagnostic role of electrical devices in acute heart failure. Heart Fail Rev 2007;12:157-66.
20. Voss F, Becker R, Hauck M, Katus HA, Bauer A. The basic pacing rate in CRT patients: the higher the better? Clin Res Cardiol 2009;98:219-23.
21. Azevedo ER, Newton GE, Floras JS, Parker JD. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure. Circulation 2000;101:2053-9.
22. Wallin BG, Sundlof G. A quantitative study of muscle nerve sympathetic activity in resting normotensive and hypertensive subjects. Hypertension 1979;1:67-77.
23. Segerson NM, Wasmund SL, Daccarett M, Fabela ML, Hammond CH, Stoddard G et al. The acute effect of atrioventricular pacing on sympathetic nerve activity in patients with normal and depressed left ventricular function. Am J Physiol Heart Circ Physiol 2008;295:H1076-80.
24. Scharf C, Li P, Muntwyler J, Chugh A, Oral H, Pelosi F et al. Rate-dependent AV delay optimization in cardiac resynchronization therapy. Pacing Clin Electrophysiol 2005;28:279-84.
25. Grimm RA, Sun JP, Agler D, Fitzgerald B, Wilkoff B, Hilpisch K et al. Shorter AV delays provide improved echocardiographic hemodynamics during exercise in patients receiving cardiac resynchronization therapy. Pacing Clin Electrophysiol 2009;32:457-65.
26. Valzania C, Eriksson MJ, Boriani G, Gadler F. Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods. Europace 2008;10:1161-9.
27. Braunschweig F, Kjellstrom B, Gadler F, Linde C. Optimization of cardiac resyn-chronization therapy by continuous hemodynamic monitoring.J Cardiovasc Electro-physiol 2004;15:94-6.
28. Stahlberg M, Damgaard M, Norsk P, Gabrielsen A, Sahlen A, Linde C et al. Cardiac output response to changes of the atrioventricular delay in different body pos-itions and during exercise in patients receiving cardiac resynchronization therapy. Europace 2009; 11: 1160-7.
29. Adamson PB, Magalski A, Braunschweig F, Bohm M, Reynolds D, Steinhaus D et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system.J Am Coll Cardiol 2003;41:565-71.
30. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.J Am Coll Cardiol 2008;51:1073-9.
31. Adamson PB, Conti JB, Smith AL, Abraham WT, Aaron MF, Aranda JM Jr et al. Reducing events in patients with chronic heart failure (REDUCEhf) study design: continuous hemodynamic monitoring with an implantable defibrillator. Clin Cardiol 2007;30:567-75.